Bubs Australia Ltd. (AU:BUB) has released an update.
Bubs Australia Ltd. has reported substantial growth in the U.S. market, with weekly revenue from infant formula sales exceeding US$1 million, making it the number one seller on Amazon USA in May 2024. The company is also making progress on the FDA’s permanent access pathway, with a significant portion of their clinical trial target enrollment achieved. Additionally, the Chinese market shows signs of recovery, with new product launches and expanded retail presence, setting a strong foundation for anticipated growth in FY25.
For further insights into AU:BUB stock, check out TipRanks’ Stock Analysis page.
